Introduction
One of the objectives of the World Marrow Donor Association (WMDA) is to establish internationally acceptable recommendations, standards and procedures for the search for unrelated volunteer haematopoietic stem cell (HSC) donors, on behalf of patients in need of transplantation. [1] [2] [3] Two of the WMDA's working groups, the Clinical and Quality Assurance Working Groups, collaborated in the development of these guidelines.
This document presents recommendations and eligibility criteria for the evaluation of volunteer donor health at recruitment and during the following donor selection procedures. The major goal of an unrelated donor registry is to create a file of well-informed and well-selected volunteers, with the greatest likelihood of being suitable donors if chosen for specific patients. The loss of a registered donor under consideration as a match for a searching patient, through medical deferral or by withdrawal for personal reasons, leads to a loss of precious time and money during the search process and, more importantly, can drastically impact on a patient's chances to receive a transplant. It is, therefore, of fundamental importance to focus efforts on the overall medical evaluation of the volunteer before recruitment into the registry as well as in the following selection phases.
The purpose of the WMDA recommendations is to provide Donor Centres responsible for the recruitment of potential donors, with general principles and minimum criteria for the registration and further evaluation of an individual who has volunteered as a potential stem cell donor. This document recognizes that the recommendations contained herein may be subject to variances in order to meet the legal requirements of individual countries. Nevertheless, the extent of international cooperation establishes sufficient common denominators for the recommendations to be widely adhered to in the interest of best practice.
Donor evaluation
When an individual is recruited as a volunteer donor, the primary goal is to determine if the volunteer is in good health in order to (1) protect the volunteer from the risk of damage to his/her own health, and (2) protect the recipient from transmissible diseases. It is, therefore, an essential requirement that only individuals in good health, who meet specific eligibility criteria, should be registered as potential stem cell donors. The Donor Centre, in accordance with the Registry standards and national laws, must also comply with established age, height and weight criteria.
During HSC donation, infectious agents (hepatitis B and C viruses, human immunodeficiency virus, and so on), genetic defects or even disseminated malignancies can be transmitted. Assessing these risks of disease transmission and of donation requires that the examiner obtains a concise medical and life-style history and requests laboratory tests that have not always been done at time of first registration of volunteers. Screening questionnaires are helpful to obtain complete and relevant information on the donor's medical history and general health.
A pre-printed questionnaire should be completed at recruitment (a sample can be found in Appendix 1). A second questionnaire must be completed when a donor is being considered for a specific patient (for example requested for confirmatory typing). A sample questionnaire can be found in Appendix 2. The questionnaires should be designed to elicit information relevant to potential selection of that individual as a stem cell donor. The questionnaires should be also supplemented, where necessary, by direct questioning. Some specific questions asked of donors are designed to identify individuals who may be at a high risk of transmitting infectious diseases. A positive response to these questions will, in general, lead to a temporary or permanent deferral but in each case it must be considered on its own merits. Since questioning of the volunteers as to the country(ies) in which they were born, were brought up or have visited is essential for effective detection, every Donor Centre should have a map of the endemic zones and an alphabetical list of the countries concerned. All donors should be provided with accurate and updated information on specific infectious diseases including human immunodeficiency virus and hepatitis transmission so that those indulging in unsafe sex practices or other risk behaviour exposing them to potential infectious sources will refrain from donating. The information provided may vary between countries according to local epidemiological data. The questionnaire should be signed by the donor and the person who carries out the medical evaluation certifying that the relevant questions have been asked.
Based on the information obtained through the questionnaires, the guidelines provided in Tables 1-6 should be followed. Table 1 lists conditions that should lead to permanent deferral of the volunteer. Table 2 lists infectious diseases, some of which result in permanent deferral and Table 3 discusses volunteers who have had close contact with infected individuals. A list of temporary deferral conditions is provided in Table 4 . Since it is unusual that a potential donor is asked to donate within a few months of his/her registration, volunteers with a condition with a deferral period of less than 6 months may be recruited onto the registry. This deferral period should be noted in the donor's record. Table 5 lists a variety of common immunizations and the deferral status of volunteers who have received them. As donors may present with a variety of medical problems, past or present, only some of the more common examples which require individual assessment by the Donor Centre are considered in Table 6 .
The donor's medical history must be evaluated before approving a volunteer as a potential donor. Abnormal findings must be referred to the physician in charge, who makes the final decision on the eligibility of the volunteer to be listed on the Registry or to be considered as a potential donor. If the physician is in doubt, the volunteer should be deferred. The volunteer must be informed about the reason for deferral and, if appropriate, any consequences to his/ her health.
Summary
Donor assessment and testing are very important issues affecting quality and safety of donation. The international legislative frameworks (European directives for donor of tissue and cellular therapy products, US Food and Drug Glaucoma, Ablatio retinae Heart Individuals with a history of heart disease, especially coronary disease, angina pectoris, severe cardiac arrhythmia; see also Table 6 for hypertension Infectious conditions See Table 2 for specific infections causing permanent deferral Latex allergy A history of hypersensitivity reactions to latex due to the increased anaesthetic risk Liver disease
Serious liver disease such as hepatitis B and C ( All volunteers found to have a confirmed positive marker for HIV must be permanently deferred. A decision regarding deferral of donors found to have a repeat reactive marker for HIV which cannot be confirmed should be made according to the nationally agreed algorithm.
In the best interests of the recipients, once an indeterminate or inconclusive result is obtained, the donor should be permanently deferred Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections Individuals with a history of jaundice or hepatitis may, at the discretion of the appropriate competent medical authority, be accepted as stem cell donors provided approved tests for Hepatis B surface antigen (HBsAg), antibodies to hepatitis C virus (anti-HCV), HCV NAT are negative. Persons whose blood gives a positive reaction for the presence of HBsAg and/ or anti-HCV must be permanently deferred. The presence of anti-HBs does not prevent donation. A decision regarding deferral of donors found to have a repeat reactive marker for HBV or HCV which cannot be confirmed should be made according to the nationally agreed algorithm. In the best interests of the recipients once an indeterminate or inconclusive result is obtained, the donor should be permanently deferred. Persons who have been in sexual contact with or in the same household as a person with viral hepatitis or who have received a transfusion of blood or blood products should have a deferral period of 12 months from the time of contact unless demonstrated to be immune. The same is true for acupuncture performed by other than a registered practitioner, tattooing and body piercing ( Abbreviation: NAT ¼ nucleic acid testing.
Table 3
Consideration of the risks associated with specific sexual partners or the risks associated with other close contact with persons with infectious diseases If contact with an infectious disease, the deferral period should equal the incubation period or, if unknown, the nature of the contact and the deferral period should be determined by the responsible physician Contact with patients with rubella, measles, mumps should result in 3 weeks deferral Current sexual partners of people with HIV should be deferred Previous sexual partners of people with HIV are acceptable after 1 year since their last sexual contact Current sexual partners of people with HBV should be deferred unless demonstrated to be immune Persons in the same household with a person with viral hepatitis should have a deferral period of 12 months from the time of contact unless demonstrated to be immune Hospital staffs coming into direct contact with patients with hepatitis are accepted at the discretion of the physician in charge, providing they have not suffered an inoculation injury or mucous membrane exposure. If exposed they should be deferred for 12 months Previous sexual partners of people with HBV are acceptable after 1 year since the last sexual contact Current sexual partners of people with HCV should be deferred Previous sexual partners of people with HCV are acceptable after 1 year since the last sexual contact Abbreviations: HBV ¼ Hepatitis B virus; HCV ¼ hepatitis C virus.
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Administration, and so on) have detailed requirements on donor evaluation.
The WMDA has prepared these recommendations with the intent to provide Donor Centres with general eligibility criteria for the medical evaluation of unrelated haematopoietic stem cell donors. These donor screening tools reflect WMDA recommendations to ensure donor and recipient safety and to ensure the quality of the cellular product. As standards and regulatory requirements may vary in different countries, Donor Centres must also consider local requirements when designing their donor screening materials.
WMDA recommends that Donor Centres, or the organization established to carry out the unrelated donor eligibility assessment, follow these guidelines to offer the appropriate quality of product for engrafting the patient, while protecting the health and well being of the volunteer donor. Table 4 Conditions leading to temporary deferral
Condition Deferral period
Endoscopy with biopsy using flexible instruments 12 months Epilepsy 3 years off treatment and without an attack Fever above 38 1C, flu-like illness 2 weeks following cessation of symptoms Kidney disease/acute glomerulonephritis 5 years deferral period following complete recovery Medication (it is recommended that a list of commonly used drugs, with rules for acceptability of donors approved by the medical staff of the Donor Centre, be available)
The taking of a medication may indicate an underlying disease which may disqualify the donor. Donors treated with drugs with a proven teratogenic effect should be deferred for a period consistent with the pharmacokinetic properties of the drug. Donors treated with drugs with a proven haematotoxicity effect should be deferred for a period consistent with the pharmacokinetic properties of the drug Piercing (body, skin, ear) 12 months Pregnancy/abortion 1 year after the delivery Rheumatic fever 2 years following attack with no evidence of chronic heart disease; the latter complication is a cause for permanent deferral Surgery
Major surgery: generally 6 months deferral. Minor surgery (for example tooth extraction): 1-week deferral if no complications. Individuals with a history of resection of the stomach are usually permanently deferred Tattoo 12 months Transfusion 12 months following transfusion with blood or blood components. Injection of blood components as part of an approved immunization programme will need clinical assessment 
